PRTA Q4 2022 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M+4159.6% YoY

Gross Profit

$13M26.1% margin

Operating Income

-$72,000-0.1% margin

Net Income

$6M12.7% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+3190.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$758M

Total Liabilities

$136M

Stockholders' Equity

$622M

Cash & Equivalents

$710M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$1M	+4159.6%
Gross Profit	$13M	-$21M	+162.5%
Operating Income	-$72,000	-$33M	+99.8%
Net Income	$6M	-$33M	+119.1%

Revenue Segments

License

$40M80%

Collaboration

$10M20%